Athelas is a patient monitoring startup that creates technologies for chronic care management in the home, partnering with hospitals and health systems so providers can give their patients remote monitoring tools without incurring upfront costs.

Athelas' mission is to bring simple, life-changing health care products to people around the globe.

Athelas was founded in 2016 by Tanay Tandon, with Deepika Bodapati. The company is headquarter in Mountain View, California.


Athelas brings together everything you need to monitor patients via internet-connected smart devices. You'll have access to state-of-the-art technologies and ground breaking AI powered analysis.


Athelas' flagship product, the Athelas One, uses a finger prick to draw blood and share metrics like white blood cell count with providers. It also offers a connected glucometer, blood pressure cuff, scale and medication-tracking device.


Athelas now serves more than 40,000 patients with chronic conditions like hypertension, cardiac disorders and immunosuppression, making it the largest provider of remote patient monitoring services in the U.S., according to the company.


Athelas is backed by General Catalyst, Tribe Capital, Sequoia Capital, YCombinator, Greenoaks, Human Capital, Initialized Capital, and others. The company announced closing of $132M across two rounds on Jan 31, 2022. This brings Athelas' total funding to $150.1M to date. The latest investment valued Athelas at a $1.5B post-money.



  • Year founded: 2021
  • Funding Info: $150.1M over 4 Rounds (Latest Funding Type: Venture- Series Unknown)
  • Yearly Revenue: NA
  • Employee Size: 51-200
  • Business Valuation: Valued at $1.5B as of Jan 31, 2022
  • City/Town: Mountain View
  • State: California
  • Country: United States
Related businesses